Enanta Pharmaceuticals
ENTA
ENTA
169 hedge funds and large institutions have $1.4B invested in Enanta Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
3% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 66
6% less funds holding
Funds holding: 179 → 169 (-10)
34% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 29
Holders
169
Holding in Top 10
4
Calls
$4.49M
Puts
$1.76M
Top Buyers
| 1 | +$68.6M | |
| 2 | +$17.2M | |
| 3 | +$14.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.9M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$8.54M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$12.4M | |
| 3 | -$10.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$8.24M |
| 5 |
Renaissance Technologies
New York
|
-$7.64M |